Omega Therapeutics, Inc. (OMGA)

2.4000 -0.0200 (-0.83%) 收市：04:00PM EDT

Omega Therapeutics, Inc.

20 Acorn Park Drive
Cambridge, MA 02140
United States
617 949 4360
https://omegatherapeutics.com

版塊: Healthcare
行業: Biotechnology
全職員工: 93

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Mahesh Karande	President, CEO & Board Director	910.39k	無	1974
Ms. Barbara Y. Chan	Principal Financial Office, Principal Accounting Officer & Chief Accounting Officer	無	無	1964
Dr. Thomas McCauley Ph.D.	Chief Scientific Officer	588.5k	無	1969
Ms. Eva Stroynowski	Senior Vice President of Investor Relations & Corporate Affairs	無	無	無
Mr. Anthony Mullin	Chief People Officer	無	無	無
Mr. Charles O'Donnell Ph.D.	VP and Head of Computational Genomics & Data Sciences	無	無	無
Dr. Kaan Certel Ph.D.	Chief Business Officer	無	無	無
Ms. Lisamarie Fahy	Senior Vice President of Clinical Development Operations	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

公司管治

截至 2024年6月1日 止，Omega Therapeutics, Inc. 的 ISS 管治質素評分為 9。 Pillar 分數正在審核中：3；董事會：10；股東權利：9；現金賠償：8。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。